Terms: = Liver cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1
260 results:
1. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
2. cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.
Ramirez CFA; Taranto D; Ando-Kuri M; de Groot MHP; Tsouri E; Huang Z; de Groot D; Kluin RJC; Kloosterman DJ; Verheij J; Xu J; Vegna S; Akkari L
Nat Commun; 2024 Mar; 15(1):2581. PubMed ID: 38519484
[TBL] [Abstract] [Full Text] [Related]
3. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
[TBL] [Abstract] [Full Text] [Related]
4. Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Karapetis CS; Liu H; Sorich MJ; Pederson LD; Van Cutsem E; Maughan T; Douillard JY; O'Callaghan CJ; Jonker D; Bokemeyer C; Sobrero A; Cremolini C; Chibaudel B; Zalcberg J; Adams R; Buyse M; Peeters M; Yoshino T; de Gramont A; Shi Q
Br J Cancer; 2024 May; 130(8):1269-1278. PubMed ID: 38402342
[TBL] [Abstract] [Full Text] [Related]
5. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal cancer Patients: An Exploratory Study.
Cayún JP; Cerpa LC; Colombo A; Cáceres DD; Leal JL; Reyes F; Gutiérrez-Cáceres C; Calfunao S; Varela NM; Quiñones LA
Curr Oncol; 2024 Jan; 31(1):274-295. PubMed ID: 38248103
[TBL] [Abstract] [Full Text] [Related]
6. ZBTB7B is a permissive regulator of hepatocellular carcinoma initiation by repressing c-Jun expression and function.
Zhu Y; Wang Q; Xie X; Ma C; Qiao Y; Zhang Y; Wu Y; Gao Y; Jiang J; Liu X; Chen J; Li C; Ge G
Cell Death Dis; 2024 Jan; 15(1):55. PubMed ID: 38225233
[TBL] [Abstract] [Full Text] [Related]
7. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies.
Chi Y; Yuan H; Fan Q; Wang Z; Niu Z; Yu J; Yuan D
Gene; 2024 Mar; 899():148134. PubMed ID: 38185290
[TBL] [Abstract] [Full Text] [Related]
8. Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal cancer after Treatment Termination.
Simmons K; Thomas JV; Ludford K; Willis JA; Higbie VS; Raghav KPS; Johnson B; Dasari A; Kee BK; Parseghian CM; Lee MS; Le PH; Morelli MP; Shen JP; Bent A; Vilar E; Wolff RA; Kopetz S; Overman MJ; Morris VK
Cancer Res Commun; 2023 Dec; 3(12):2510-2517. PubMed ID: 38085001
[TBL] [Abstract] [Full Text] [Related]
9. Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma.
Zhou S; Sarabia SF; Estrine D; Ostrow D; Schmidt RJ; Warren M; Raca G; Shillingford N; Wang L; Pawel B; Stein JE; Biegel JA; Lopez-Terrada D; Mascarenhas L; Ji J
Mod Pathol; 2024 Feb; 37(2):100385. PubMed ID: 37992967
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
11. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
12. Endoscopic features with associated histological and molecular alterations in serrated polyps with dysplasia: Retrospective analysis of a tertiary case series.
Trecca A; Borghini R; Medicina D; Del Sordo R; Mandelli G; Bella A; Galloro G; Fu KI; Villanacci V
Dig Liver Dis; 2024 Apr; 56(4):687-694. PubMed ID: 37778895
[TBL] [Abstract] [Full Text] [Related]
13. CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes.
Ning Q; Yang T; Guo X; Huang Y; Gao Y; Liu M; Yang P; Guan Y; Liu N; Wang Y; Chen D
J Viral Hepat; 2023 Dec; 30(12):951-958. PubMed ID: 37735836
[TBL] [Abstract] [Full Text] [Related]
14. Neuroblastoma RAS viral oncogene homolog (n-ras) deficiency aggravates liver injury and fibrosis.
Zheng K; Hao F; Medrano-Garcia S; Chen C; Guo F; Morán-Blanco L; Rodríguez-Perales S; Torres-Ruiz R; Peligros MI; Vaquero J; Bañares R; Gómez Del Moral M; Regueiro JR; Martínez-Naves E; Mohamed MR; Gallego-Durán R; Maya D; Ampuero J; Romero-Gómez M; Gilbert-Ramos A; Guixé-Muntet S; Fernández-Iglesias A; Gracia-Sancho J; Coll M; Graupera I; Ginès P; Ciudin A; Rivera-Esteban J; Pericàs JM; Frutos MD; Ramos Molina B; Herranz JM; Ávila MA; Nevzorova YA; Fernández-Malavé E; Cubero FJ
Cell Death Dis; 2023 Aug; 14(8):514. PubMed ID: 37563155
[TBL] [Abstract] [Full Text] [Related]
15. Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/nras/BRAF mutations or right-sided colon cancer: a retrospective cohort study.
Chang W; Chen Y; Zhou S; Ren L; Xu Y; Zhu D; Tang W; Ye Q; Wang X; Fan J; Wei Y; Xu J
Int J Surg; 2023 Oct; 109(10):3070-3077. PubMed ID: 37526097
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of
Lastraioli E; Bettiol A; Iorio J; Limatola E; Checcacci D; Parisi E; Bianchi C; Arcangeli A; Iannopollo M; Di Costanzo F; Di Lieto M
Cells; 2023 May; 12(11):. PubMed ID: 37296579
[TBL] [Abstract] [Full Text] [Related]
18. The genomics of liver metastases from colon and rectal cancer: An Invited Commentary (invitation from Lee Ocuin, MD and Kevin Behrns, MD) for the special issue of "Management of Advanced Primary and Secondary liver Malignancies".
Schwantes IR; Mayo SC
Surgery; 2023 Aug; 174(2):422-424. PubMed ID: 37183133
[TBL] [Abstract] [Full Text] [Related]
19. nras-mutated oncocytic benign liver lesion in an organ donor: Pitfalls and troubles in frozen section diagnosis and risk assessment.
Simoncini G; Orsatti A; Malvi D; Tardio ML; Maloberti T; de Biase D; D'Errico A; Vasuri F
Pathol Res Pract; 2023 Jun; 246():154531. PubMed ID: 37182314
[TBL] [Abstract] [Full Text] [Related]
20. Hepatic passaging of nras-mutant melanoma influences adhesive properties and metastatic pattern.
Dietsch B; Weller C; Sticht C; de la Torre C; Kramer M; Goerdt S; Géraud C; Wohlfeil SA
BMC Cancer; 2023 May; 23(1):436. PubMed ID: 37179302
[TBL] [Abstract] [Full Text] [Related]
[Next]
